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To reinvigorate medicine and provide a useful information tool
for clinicians and patients
Why would anybody want to publish a journal that is a
mountain of case reports? Aren't case reports scientifically
discredited? And why in particular would an old stager
like me, once editor of the BMJ and strongly associated
with evidence-based medicine, want to be the Editor-in-
Chief of such a journal [1]? These are questions that I've
had to answer to my own satisfaction to take on the job
and that I need to answer to your satisfaction if you are
ever to access this journal again.
The case for top of the range case reports has already been
convincingly made - both by our academic sister publica-
tion [2] and by Jan Vandenbroucke, one of the wisest
heads in medical science [3,4]. By definition every new
condition - whether it s AIDS, SARS, or the next emergent
disease - begins with a single case. Case reports have
always been important for detecting adverse drug reac-
tions [5,6]. They also matter in understanding mechanism
of disease and for recognising rare manifestations of dis-
eases. Jeff Aronson and others have described circum-
stances where case reports can provide definitive not just
indicative evidence [7,8].
But what is the case for mass publication of case reports
such as this journal hopes to achieve? And we will publish
any case report that is authentic, understandable, and eth-
ical. It might be an account of a cold sore or, as on this
launch, a description of my "Beijing cough" that includes
no health professional and no treatment. Our radical con-
tention - which is perhaps not so radical to medical teach-
ers - is that every case is important. And we don't have to
destroy trees: we can luxuriate in the infinity of cyberspace
- and readers can search our database for whatever they
fancy.
Health care is in some ways nothing more than an accu-
mulation of case reports just as a population is a collec-
tion of people. And just as every person is important and
different so is every case - even when "it's just another sore
throat". Indeed, part of the idea is to get away from seeing
a morning surgery in general practice or an afternoon's list
of men undergoing vasectomy as drudgery or factory
work. Clinicians have the privilege of dealing with indi-
viduals in all their complexity and magnificence. Every
person, every "case" can teach us something. We challenge
contributors to draw out the lessons - but they don't have
to succeed in order to be published because readers may
see what they can't and there will be value in the mass that
may not be immediately apparent in the single case.
Perhaps some of our contributors will attempt to write
case histories like those of Sigmund Freud. To catch the
full mystery, excitement, and interest of a case may
demand literary skills, and we know that many clinicians
and even more patients have such skills. Jean Cocteau
asked his doctor why he continued to attend him day and
night at his home and the answer was that the doctors
learnt from Cocteau because of his ability to describe his
symptoms [9]. Cocteau produced a quote that is directly
relevant to this endeavour: "Take a commonplace, clean it
and polish it, light it so that it produces the same effect of
youth and freshness and originality and spontaneity as it
did originally, and you have done a poet's job. The rest is
literature".
A mass collection of case reports can have practical value
for both practitioners and policy makers. The BEACH
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in Australia has used 100 consecutive case reports from a
random sample of general practitioners drawn each year
to describe "the characteristics of GPs and the patients
who consult them, patient reasons for encounter, the
problems managed and management techniques used"
[10]. It has gone on now for 10 years and so can plot
changes in practice. The programme has been very impor-
tant in developing general practice in Australia.
But this publication will not be a random sample. It will
be accumulation of cases. So can they be of any use clini-
cally? Let us consider the case of a doctor faced with a 75-
year-old man who is a smoker, had an acute myocardial
infarction five years ago, and has chronic obstructive lung
disease, arthritis, and depression. Such a combination is
not unusual: 40% of patients with long-term conditions
have more than one condition, and many have three or
more [11]. As Sir Michael Rawlins, chair of the National
Institute of Health and Clinical Excellence, showed at a
workshop two years ago, follow the NICE guidelines for
each condition and the patient will end up in a mess -
because NICE guidelines don't deal with comorbidities.
More profoundly, they probably never can: the guidelines
are based on trials that deliberately excluded patients with
comorbidites. You can never do randomised trials on
every kind of patient - the patients that GPs meet every day
of the week.
What is the answer? GPs might, and will, use their experi-
ence - as they have done for centuries. Their experience
might be supplemented with evidence from high quality
databases that follow every one of a cohort of patients
[12]. But they might also search our journal and database
to find a patient just like theirs and see how the patient
was treated and what happened to him or her (follow up
will be very important for our database - see accompany-
ing editorial [13]). Or they might ask in our journal
whether anybody has evidence on such a patient. But - an
evidence-based purist might argue - this isn't unbiased
information: such information is scientifically uninter-
pretable. The crucial question, however, is whether it's
better than nothing. I believe it is. Nick Wald and Joan
Morris have argued the case for teleoanalysis - combining
evidence of different types - in addition to meta-analysis
[14]. Meanwhile, Alejandro R Jadad and Murray W Enkin,
two of the great advocates of randomised trials, have writ-
ten: "Our main wish, from which all others stem, is that
RCTs be taken off their pedestal, their exalted position at
the top of an artificial evidence hierarchy, that all forms of
evidence be appreciated for what they can offer" [15].
Case reports have something to offer. Plus a combination
of being able to ask questions plus open access for all gives
us a route the "wisdom of crowds". James Surowiecki
shows convincingly in his book of that name how the
many can be much smarter than the few [16]. He begins
his book with the story - or case report - of Francis Galton,
one of the fathers of statistics and an enthusiast for eugen-
ics, studying the results of a guess the weight of the ox
competition at a country fair - expecting to find evidence
that superior people were best at guessing the weight. He
didn't find that. What he did find was that the average of
the guesses of the whole crowd came astonishingly close.
The crowd is smarter than the individuals within it.
Crowds can, of course, be dramatically wrong - for exam-
ple, in knowing the world to be flat - and it's important
how we capture the wisdom of crowds.
Ben Shneiderman has written recently in Science magazine
about the need for what he calls Science 2.0 [17]. Science
1.0 of hypothesis generation and testing remains impor-
tant, but Science 2.0 will help us understand "challenges
[that] cannot be studied adequately in laboratory condi-
tions because controlled experiments do not capture the
rich context of Web 2.0 collaboration, where the interac-
tion among variables undermines the validity of reduc-
tionist methods". Reductionist methods struggle with the
problem of comorbidities and fail to recognise that
patients are much more than specimens with a collection
of disease but rather complex individuals with their own
values. Ours is, I think, a Science 2.0 experiment.
There are then more frivolous - but still important - rea-
sons for encouraging mass publication of case reports.
Doctors - just like everybody else - relate more to stories
than they do to statistics and abstractions. Successful pol-
iticians understand this well - eschewing complicated
numbers for powerful human stories. And this is the age
of Web 2.0 and Facebook. We are fed up listening to
experts and watching the same old television channels.
We want to create our own material, live in a bottom up
rather than a top down world. That's perhaps why our sis-
ter journal and Sermo, "a practicing [online] community
of 50,000 physicians [in the US] who exchange clinical
insights, observations, and review cases in realtime - all
the time", are doing so well [18]. Here on our site every-
body who sees a patient - and everybody who is a patient
(that's everybody) - can contribute. We urge you to do so.
Let's see if we can create something exciting, special, new,
fun, and useful.
I'm grateful to the many people who commented on drafts of
this editorial, but I'm painfully conscious that I haven't
responded to all of their comments. In fact I've ignored most of
them - not because they were silly or wrong but rather that this
piece is my silliness and wrongness and because writing in a
crowd is hard. Wisdom will come not from endlessly refining
this editorial but rather from debating its strengths and weak-
nesses. I encourage those whom I've ignored to respond.Page 2 of 3
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